NCT04727853 2024-07-10Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC)CSPC Ouyi Pharmaceutical Co., Ltd.Phase 2 Completed66 enrolled